Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bottomly

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Nature Communications|January 18, 2019
Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanismsHaijiao Zhang, Samantha Savage, Anna Reister Schultz, et al.
Blood|August 2, 2019
Genomic landscape of neutrophilic leukemias of ambiguous diagnosisHaijiao Zhang, Beth Wilmot, Daniel Bottomly, et al.
Cancer Cell|June 25, 2021
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistanceSunil K Joshi, Tamilla Nechiporuk, Daniel Bottomly, et al.
Nature Genetics|October 4, 2024
Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemiaAndrew Stiff, Maarten Fornerod, Bailee N Kain, et al.
Nature|October 19, 2018
Functional genomic landscape of acute myeloid leukaemiaJeffrey W Tyner, Cristina E Tognon, Daniel Bottomly, et al.
Cancer Cell|July 22, 2022
Integrative analysis of drug response and clinical outcome in acute myeloid leukemiaDaniel Bottomly, Nicola Long, Anna Reister Schultz, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Nature Communications|January 18, 2019
Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanismsHaijiao Zhang, Samantha Savage, Anna Reister Schultz, et al.
Blood|August 2, 2019
Genomic landscape of neutrophilic leukemias of ambiguous diagnosisHaijiao Zhang, Beth Wilmot, Daniel Bottomly, et al.
Cancer Cell|June 25, 2021
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistanceSunil K Joshi, Tamilla Nechiporuk, Daniel Bottomly, et al.
Nature Genetics|October 4, 2024
Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemiaAndrew Stiff, Maarten Fornerod, Bailee N Kain, et al.
Nature|October 19, 2018
Functional genomic landscape of acute myeloid leukaemiaJeffrey W Tyner, Cristina E Tognon, Daniel Bottomly, et al.
Cancer Cell|July 22, 2022
Integrative analysis of drug response and clinical outcome in acute myeloid leukemiaDaniel Bottomly, Nicola Long, Anna Reister Schultz, et al.
Pageof 6